Korea Investment Corp Incyte Corp Transaction History

Korea Investment Corp

$41.3 Billion
Q3 2024

A detailed history of Korea Investment Corp transactions in Incyte Corp stock. As of the latest transaction made, Korea Investment Corp holds 58,726 shares of INCY stock, worth $4.46 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

58,726

Previous 121,041 51.48%

Holding current value

$4.46 Million

Previous $7.34 Million 47.1%

% of portfolio

0.01%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$57.33 - $68.61 $3.57 Million - $4.28 Million	-62,315 Reduced 51.48%	58,726 $3.88 Million
Q2 2024 Aug 13, 2024	SELL	$51.18 - $63.75 $5.99 Million - $7.46 Million	-117,039 Reduced 49.16%	121,041 $7.34 Million
Q1 2024 May 14, 2024	BUY	$56.55 - $66.59 $73,288 - $86,300	1,296 Added 0.55%	238,080 $13.6 Million
Q4 2023 Feb 13, 2024	BUY	$52.16 - $64.19 $7.43 Million - $9.15 Million	142,514 Added 151.18%	236,784 $14.9 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $1.29 Million - $1.47 Million	22,295 Added 30.98%	94,270 $5.45 Million
Q2 2023 Aug 11, 2023	SELL	$60.95 - $75.51 $20 Million - $24.8 Million	-328,332 Reduced 82.02%	71,975 $4.48 Million
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $11.8 Million - $14.4 Million	167,819 Added 72.18%	400,307 $28.9 Million
Q4 2022 Feb 13, 2023	BUY	$67.18 - $84.11 $9.55 Million - $12 Million	142,158 Added 157.38%	232,488 $18.7 Million
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $1.94 Million - $2.43 Million	29,291 Added 47.99%	90,330 $6.02 Million
Q2 2022 Aug 12, 2022	SELL	$66.18 - $83.18 $341,554 - $429,291	-5,161 Reduced 7.8%	61,039 $4.64 Million
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $6.35 Million - $7.67 Million	-96,200 Reduced 59.24%	66,200 $5.26 Million
Q4 2021 Feb 09, 2022	BUY	$63.34 - $74.11 $57,006 - $66,699	900 Added 0.56%	162,400 $11.9 Million
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $4.06 Million - $4.97 Million	-59,100 Reduced 26.79%	161,500 $11.1 Million
Q2 2021 Aug 12, 2021	BUY	$79.87 - $87.53 $14.2 Million - $15.6 Million	178,400 Added 422.75%	220,600 $18.6 Million
Q1 2021 May 13, 2021	SELL	$76.02 - $100.5 $722,190 - $954,750	-9,500 Reduced 18.38%	42,200 $3.43 Million
Q4 2020 Feb 10, 2021	SELL	$80.74 - $97.7 $662,068 - $801,140	-8,200 Reduced 13.69%	51,700 $4.5 Million
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $1.48 Million - $1.91 Million	-17,400 Reduced 22.51%	59,900 $5.38 Million
Q2 2020 Aug 12, 2020	BUY	$74.18 - $108.93 $1.16 Million - $1.71 Million	15,700 Added 25.49%	77,300 $8.04 Million
Q1 2020 May 14, 2020	SELL	$63.18 - $85.97 $1.54 Million - $2.09 Million	-24,300 Reduced 28.29%	61,600 $4.51 Million
Q4 2019 Feb 11, 2020	SELL	$73.04 - $95.72 $1.05 Million - $1.38 Million	-14,400 Reduced 14.36%	85,900 $7.5 Million
Q3 2019 Nov 12, 2019	BUY	$72.82 - $86.52 $43,691 - $51,912	600 Added 0.6%	100,300 $7.45 Million
Q2 2019 Aug 12, 2019	BUY	$73.52 - $88.7 $1.37 Million - $1.65 Million	18,600 Added 22.93%	99,700 $8.47 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $4.78 Million - $6.63 Million	75,186 Added 1271.32%	81,100 $6.98 Million
Q4 2018 Feb 13, 2019	SELL	$58.5 - $69.94 $52,708 - $63,015	-901 Reduced 13.22%	5,914 $376,000
Q3 2018 Nov 13, 2018	SELL	$61.75 - $74.23 $3.49 Million - $4.2 Million	-56,580 Reduced 89.25%	6,815 $471,000
Q2 2018 Aug 13, 2018	SELL	$60.85 - $83.98 $4.12 Million - $5.69 Million	-67,730 Reduced 51.65%	63,395 $0
Q1 2018 May 09, 2018	BUY	$83.06 - $100.98 $1.26 Million - $1.53 Million	15,201 Added 13.11%	131,125 $10.9 Million
Q4 2017 Feb 12, 2018	BUY	$93.56 - $116.6 $3.83 Million - $4.77 Million	40,920 Added 54.56%	115,924 $11 Million
Q3 2017 Oct 25, 2017	BUY	$109.15 - $138.27 $8.19 Million - $10.4 Million	75,004	75,004 $8.76 Million

Others Institutions Holding INCY

# of Institutions

641

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.

Account

Korea Investment Corp Incyte Corp Transaction History